T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy

Clinical and Experimental Immunology

Volumn 153, Issue 3, 2008, Pages 456-462

  Chintalacharuvu, S R ^a   Yamashita, M ^a   Bagheri, N ^a   Blanchard, T G ^b   Nedrud, J G ^a   Lamm, M E ^a   Tomino, Y ^c   Emancipator, S N ^a,d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

Cytokine polarity; Glycosylation; IgA nephropathy; Sendai virus; T cell

Indexed keywords

CREATININE; CYTOKINE; FREUND ADJUVANT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POLARITY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULONEPHRITIS; GLYCOSYLATION; HELPER CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN A NEPHROPATHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENDAI VIRUS; SIALYLATION; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VIRUS INACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FREUND'S ADJUVANT; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIPIDS; MICE; MICE, INBRED BALB C; NASAL LAVAGE FLUID; SENDAI VIRUS; TH1 CELLS; TH2 CELLS;

EID: 49649116884     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03703.x     Document Type: Article

References (33)

1. Emancipator SN. Ig A nephropathy and Henoch-Schönlein syndrome. In : Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstall's pathology of the kidney, 5th edn. Philadelphia, PA : Lippincott-Raven, 1998 : 479 540.
2. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004 24 : 179 96.
3. Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol 2005 16 : 2088 97.
4. Tomino Y. IgA nephropathy today. Basel : Karger, 2007.
5. Julian BA, Novak J. IgA nephropathy: an update. J Clin Curr Opin Nephrol Hypertens 2004 13 : 171 9.
6. Emancipator SN, Mestecky J, Lamm ME. IgA nephropathy and related diseases. In : Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, eds. Mucosal immunology, 3rd edn. San Diego : Elsevier Academic Press, 2005 : 1579 600
7. Tomana M, Novak J, Julian BA et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 1999 104 : 73 81.
8. Tomana M, Matousovic K, Julian BA et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1997 52 : 509 16.
9. Lai KN, Ho RT, Lai CK et al. Increase of both circulating Th1 and Th2 T lymphocyte subsets in IgA nephropathy. Clin Exp Immunol 1994 96 : 116 21.
10. Scivittaro V, Gesualdo L, Ranieri E et al. Profiles of immunoregulatory cytokine production in vitro in patients with IgA nephropathy and their kindred. Clin Exp Immunol 1994 96 : 311 16.
11. Scivittaro V, Ranieri E, Di Cillo M et al. In vitro immunoglobulin production in relatives of patients with IgA nephropathy. Clin Nephrol 1994 42 : 1 8.
12. Chintalacharuvu SR, Emancipator SN. The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines. J Immunol 1997 159 : 2327 33.
13. Chintalacharuvu SR, Emancipator SN. Differential glycosylation of two glycoproteins synthesized by murine B cells in response to IL-4 plus IL-5. Cytokine 2000 12 : 1182 8.
14. Chintalacharuvu SR, Nagy NU, Sigmund N et al. T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation. Clin Exp Immunol 2001 126 : 326 33.
15. Yip HC, Karulin AY, Tary-Lehmann M et al. Adjuvant-guided Type 1 and Type 2 immunity: infectious/noninfectious dichotomy defines the class of response. J Immunol 1999 162 : 3942.
16. Karulin AY, Hesse MD, Tary-Lehmann M. Single cytokine producing CD4 memory cells predominate in Type 1 and Type 2 immunity. J Immunol 2000 164 : 1862.
17. Stern BV, Boehm BO, Tary-Lehmann M. Vaccination with tumor peptide in CpG adjuvant protects via IFN-γ dependent CD4 cell immunity. J Immunol 2002 168 : 6099.
18. Nedrud JG, Liang X, Hague N et al. Combined oral/nasal immunization protects mice from Sendai virus infection. J Immunol 1987 139 : 3484 92.
19. Liang X, Lamm ME, Nedrud JG. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. J Immunol 1988 141 : 1495 501.
20. Emancipator SN. Animal models of nephropathy. In : Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds Coico R, series ed. Current protocols in immunology. New York : John Wiley & Sons, 1999 : Unit 15·11.
21. Jessen RH, Nedrud JG, Jacobs GH et al. Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependence on antigen form and immune status. Lab Invest 1992 67 : 379 86.
22. Bagheri N, Pepple DA, Hassan MO et al. Development of immune-complex glomerulonephritis in athymic mice: T cells are not required for the genesis of glomerular injury. Lab Invest 2005 85 : 354 63.
23. Emancipator SN, Rao CS, Amore A, Coppo R, Nedrud JG. Macromolecular properties that promote mesangial binding and mesangiopathic nephritis. Review. J Am Soc Nephrol 1992 2 (Suppl. 10 S149 58.
24. Hiki Y, Kokubo T, Iwase H et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 1999 10 : 760 9.
25. Sano T, Hiki Y, Kokubo T, Iwase H, Shigematsu H, Kobayashi Y. Enzymatically deglycosylated human IgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli. Nephrol Dial Transpl 2002 17 : 50 6.
26. Amore A, Conti G, Cirina P et al. Aberrantly glycosylated IgA molecules downregulate the synthesis and secretion of vascular endothelial growth factor in human mesangial cells. Am J Kidney Dis 2000 36 : 1242 52.
27. Amore A, Cirina P, Conti G, Brusa P, Peruzzi L, Coppo R. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 2001 12 : 1862 71.
28. Coppo R, Amore A. Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 2004 65 : 1544 7.
29. Xu LX, Zhao MH. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int 2005 68 : 167 72.
30. Van Den Berg JG, Aten J, Chand MA et al. Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells. J Am Soc Nephrol 2000 11 : 413 22.
31. Van Den Berg JG, Aten J, Annink C et al. Interleukin-4 and -13 promote basolateral secretion of H(+) and cathepsin L by glomerular epithelial cells. Am J Physiol Renal Physiol 2002 F26 33.
32. Rifai A, Fadden K, Morrison SL, Chintalacharuvu KR. The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes. J Exp Med 2000 191 : 2171 82.
33. Nishie T, Miyaishi O, Azuma H et al. Development of immunoglobulin A nephropathy-like disease in beta-1,4-galactosyltransferase-I-deficient mice. Am J Pathol 2007 170 : 447 56.